Assessment of Glycemic Variability
The best way to assess glycemic variability is through continuous glucose monitoring (CGM) using the coefficient of variation (%CV) as the primary metric, with a target of <36%, supplemented by time in range (TIR), time above range (TAR), and time below range (TBR) metrics from standardized CGM reports. 1
Primary Metric: Coefficient of Variation (%CV)
The %CV is the gold standard metric for assessing glycemic variability, calculated as the standard deviation of sensor glucose divided by mean sensor glucose 1. Target %CV should be ≤36%, with some evidence suggesting that lower targets (<33%) provide additional protection against hypoglycemia for patients on insulin or sulfonylureas 1.
The %CV captures both the amplitude and frequency of glucose oscillations, making it superior to metrics that only measure one dimension 2, 3. This metric is particularly valuable because it:
- Correlates directly with hypoglycemia risk
- Remains interpretable across different mean glucose levels
- Provides actionable clinical information
Standardized CGM Metrics Panel
When assessing glycemic variability comprehensively, use the international consensus standardized CGM metrics 1:
Core Metrics to Report:
- Mean glucose - reflects overall glycemic control
- Glucose Management Indicator (GMI) - estimates A1C from CGM data
- %CV - primary variability metric (target ≤36%)
- Time in Range (TIR): 70-180 mg/dL (3.9-10.0 mmol/L)
- Time Above Range (TAR): Level 1 (181-250 mg/dL) and Level 2 (>250 mg/dL)
- Time Below Range (TBR): Level 1 (54-69 mg/dL) and Level 2 (<54 mg/dL)
CGM Data Requirements
For valid assessment, ensure 1:
- Minimum 14 days of CGM wear
- At least 70% active sensor time from those 14 days
This duration and data capture rate provides sufficient information to characterize typical glycemic patterns and variability.
Interpretation Framework: The Three-Step Method
For practical clinical interpretation of CGM data, use the structured "three-step method" 4:
For 3-day CGM data:
- First: Analyze nocturnal blood glucose patterns
- Second: Examine preprandial glucose levels
- Third: Evaluate postprandial glucose excursions
At each step, prioritize in this order:
- Identify hypoglycemia first (most dangerous)
- Then assess hyperglycemia
- Finally, determine underlying causes
For 14-day CGM data:
- Analyze time to achieve glycemic targets
- Assess overall glucose fluctuations
- Quantify hypoglycemia risk
Visual Display: Ambulatory Glucose Profile (AGP)
The AGP is the recommended standardized reporting format 1, 5. It aggregates multiple days of glucose data into a 24-hour modal display showing:
- Median glucose curve (50th percentile)
- Interquartile range (25th-75th percentiles)
- 5th and 95th percentile curves
Focus on patterns and trends rather than individual glucose values 4. The AGP reveals inter-day variability and helps identify systematic problems with timing of meals, medications, or activities.
Additional Variability Metrics for Research
While %CV is the primary clinical metric, other measures capture different aspects of variability 2:
- Standard deviation (SD) - highly correlated with most variability measures
- Mean amplitude of glycemic excursion (MAGE) - captures major glucose swings
- Glucose Variability Percentage (GVP) - assesses both amplitude and frequency of oscillations 3
- Area under/above curve - quantifies time and magnitude of excursions 4
These research metrics are useful for clinical trials but add complexity without clear advantage over %CV for routine practice.
Critical Caveats
CGM calibration requirements: Some CGM systems require fingerstick blood glucose for calibration. Always perform confirmatory fingerstick testing when 5:
- CGM suggests hypoglycemia
- Patient has symptoms discordant with CGM reading
- Making acute treatment decisions
Accuracy considerations: CGM measures interstitial glucose, which lags plasma glucose by 5-15 minutes. During rapid glucose changes, CGM may not reflect current plasma values 4.
Patient factors: Robust diabetes education and training are essential for proper CGM use and interpretation 6. Patients must understand how to respond to trend arrows and alerts, not just absolute values.
Why %CV Over Other Metrics
The %CV emerged as superior because 2, 7:
- It normalizes variability to mean glucose level
- Captures both amplitude and frequency of fluctuations
- Demonstrates strong correlation with hypoglycemia risk
- Provides a single, interpretable number
- Has established clinical thresholds
Standard deviation alone is insufficient because it doesn't account for mean glucose—a patient with mean glucose of 200 mg/dL and SD of 50 has very different variability than one with mean of 100 mg/dL and SD of 50.
Integration With A1C
A1C does not measure glycemic variability or detect hypoglycemia 8, 9. Patients can have identical A1C values with vastly different variability profiles. Therefore, glycemic control assessment requires both:
- A1C for long-term average exposure
- CGM metrics (%CV, TIR, TBR) for variability and hypoglycemia risk
This combined approach provides complete characterization of glycemic control 1.